Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Capital Expenditures: 2009-2019

Historic Capital Expenditures for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to -$741.4 million.

  • Fresenius Medical Care AG's Capital Expenditures rose 317.59% to -$249.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.0 billion, marking a year-over-year increase of 972.67%. This contributed to the annual value of -$741.4 million for FY2024, which is 300.05% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Capital Expenditures of -$741.4 million as of FY2024, which was down 300.05% from -$719.8 million recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Capital Expenditures high stood at -$719.8 million for FY2023, and its period low was -$1.2 billion during FY2020.
  • Its 5-year average for Capital Expenditures is -$863.3 million, with a median of -$741.4 million in 2024.
  • In the last 5 years, Fresenius Medical Care AG's Capital Expenditures tumbled by 5030.92% in 2020 and then soared by 2364.99% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Capital Expenditures (Annual) stood at -$1.2 billion in 2020, then grew by 19.83% to -$948.4 million in 2021, then increased by 23.65% to -$724.1 million in 2022, then increased by 0.59% to -$719.8 million in 2023, then decreased by 3.0% to -$741.4 million in 2024.
  • Its Capital Expenditures stands at -$741.4 million for FY2024, versus -$719.8 million for FY2023 and -$724.1 million for FY2022.